U.S. flag

An official website of the United States government

NM_002524.5(NRAS):c.34G>C (p.Gly12Arg) AND Chronic myelogenous leukemia, BCR-ABL1 positive

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 14, 2015
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000430635.1

Allele description [Variation Report for NM_002524.5(NRAS):c.34G>C (p.Gly12Arg)]

NM_002524.5(NRAS):c.34G>C (p.Gly12Arg)

Gene:
NRAS:NRAS proto-oncogene, GTPase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p13.2
Genomic location:
Preferred name:
NM_002524.5(NRAS):c.34G>C (p.Gly12Arg)
Other names:
p.G12R:GGT>CGT
HGVS:
  • NC_000001.11:g.114716127C>G
  • NG_007572.1:g.5768G>C
  • NM_002524.5:c.34G>CMANE SELECT
  • NP_002515.1:p.Gly12Arg
  • LRG_92t1:c.34G>C
  • LRG_92:g.5768G>C
  • NC_000001.10:g.115258748C>G
  • NM_002524.3:c.34G>C
Protein change:
G12R
Links:
dbSNP: rs121913250
NCBI 1000 Genomes Browser:
rs121913250
Molecular consequence:
  • NM_002524.5:c.34G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Chronic myelogenous leukemia, BCR-ABL1 positive (CML)
Synonyms:
Chronic myeloid leukemia; Chronic granulocytic leukemia; Chronic myelogenous leukemia
Identifiers:
MONDO: MONDO:0011996; MeSH: D015464; MedGen: C0279543; Orphanet: 521; OMIM: 608232; Human Phenotype Ontology: HP:0005506

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000503740Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(Jul 14, 2015) 		somaticliterature only

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, et al.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

PubMed [citation]
PMID:
25157968
PMCID:
PMC4210463

Progression of RAS-mutant leukemia during RAF inhibitor treatment.

Callahan MK, Rampal R, Harding JJ, Klimek VM, Chung YR, Merghoub T, Wolchok JD, Solit DB, Rosen N, Abdel-Wahab O, Levine RL, Chapman PB.

N Engl J Med. 2012 Dec 13;367(24):2316-21. doi: 10.1056/NEJMoa1208958. Epub 2012 Nov 7.

PubMed [citation]
PMID:
23134356
PMCID:
PMC3627494

Details of each submission

From Database of Curated Mutations (DoCM), SCV000503740.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024